Showing results (1101-1110 of 1,135) with videos related to

Sort By:
Pageof 114
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 8, 2025
[Results of a 5-year project for the early diagnosis of multiple sclerosis in first-line blood relatives (RADIRS program)]A N Boyko, V V Gosteva, M A Omarova, et al.
Science Advances|November 27, 2024
TCF1 dosage determines cell fate during T cell developmentAnjali Verma, Bridget Aylward, Fei Ma, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 5, 2023
[Assessment of the efficacy and safety of alemtuzumab in patients with highly active relapsing-remitting multiple sclerosis in Russian population]S A Sivertseva, A M Prilenskaya, E V Popova, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|February 15, 2021
Rapid, Full-Scale Change to Virtual PCIT During the COVID-19 Pandemic: Implementation and Clinical ImplicationsDainelys Garcia, Angela M Blizzard, Abigail Peskin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2015
Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic MiceHeather I Fraser, Sarah Howlett, Jan Clark, et al.
Plos Computational Biology|July 27, 2018
OpenSim: Simulating musculoskeletal dynamics and neuromuscular control to study human and animal movementAjay Seth, Jennifer L Hicks, Thomas K Uchida, et al.
Science (New York, N.Y.)|December 9, 2017
Aging and neurodegeneration are associated with increased mutations in single human neuronsMichael A Lodato, Rachel E Rodin, Craig L Bohrson, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 11, 2015
[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]S A Rumyantsevа, A L Kovalenko, E V Silinа, et al.
Rheumatology (Oxford, England)|February 10, 2025
Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providersMatthew A Sherman, Rebecca Nicolai, Emily K Datyner, et al.
Pageof 114